Grantham, Mayo, Van Otterloo & Co (GMO)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-85,050
Closed -$4.08M 866
2020
Q1
$4.08M Buy
+85,050
New +$4.08M 0.03% 268